title: [Can the symptoms of stroke be limited?].
authors.affiliation: HYKS:n neuroklinikka, Helsinki.
authors.forename: P J
authors.initials: PJ
authors.lastname: Lindsberg
authors.forename: M
authors.initials: M
authors.lastname: Kaste
mesh_terms: D000818:Animals; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009569:Nitric Oxide / Q000378:metabolism; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000188:drug therapy* / Q000473:pathology; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D018696:Neuroprotective Agents; D016222:Fibroblast Growth Factor 2; D009569:Nitric Oxide; D010959:Tissue Plasminogen Activator